Trio Pharmaceuticals, Inc.

San Diego, CA Doing business as Trio Pharma

UEI
HNEYC4KUDKA4
CAGE
86QY3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
11956 Bernardo Plaza Dr #160, San Diego, CA 92128, USA
Website
triopharmaceuticals.com
Founded
2018
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Trio Pharmaceuticals, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A novel targeted antibody therapeutic to treat ovarian cancer - project summary ovarian cancer (ovca) is the fifth… Grant · R43CA287501 National Cancer Institute $399,478
A dual action antibody drug conjugate to treat triple negative breast cancer by enhancing tumor immunity - project… Grant · R43CA271923 National Cancer Institute $797,468

Quick answers

What is Trio Pharmaceuticals, Inc.'s UEI?

Trio Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is HNEYC4KUDKA4.

What is Trio Pharmaceuticals, Inc.'s CAGE code?

Trio Pharmaceuticals, Inc.'s CAGE code is 86QY3.

Where is Trio Pharmaceuticals, Inc. located?

Trio Pharmaceuticals, Inc.'s physical address in SAM.gov is 11956 Bernardo Plaza Dr #160, San Diego, CA 92128, USA.

Is Trio Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Trio Pharmaceuticals, Inc.'s SAM.gov registration is active through May 19, 2027.

What is Trio Pharmaceuticals, Inc.'s most recent federal award?

Trio Pharmaceuticals, Inc.'s most recent federal grant award is A novel targeted antibody therapeutic to treat ovarian cancer - project summary ovarian cancer (ovca) is the fifth… (R43CA287501), from National Cancer Institute, on June 1, 2024.

On GovTribe

See Trio Pharmaceuticals, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login